Haemonetics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Haemonetics and other ETFs, options, and stocks.

About HAE

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital.

CEO

Christopher A. Simon

CEOChristopher A. Simon

Employees

3,009

Employees3,009

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

1971

Founded1971

Employees

3,009

Employees3,009

HAE Key Statistics

Market cap

3.99B

Market cap3.99B

Price-Earnings ratio

42.24

Price-Earnings ratio42.24

Dividend yield

—

Dividend yield—

Average volume

924.82K

Average volume924.82K

High today

—

High today—

Low today

—

Low today—

Open price

$85.04

Open price$85.04

Volume

0.00

Volume0.00

52 Week high

$88.59

52 Week high$88.59

52 Week low

$47.32

52 Week low$47.32

Stock Snapshot

Haemonetics(HAE) stock is priced at $87.84, giving the company a market capitalization of 3.99B. It carries a P/E multiple of 42.24.

On 2026-08-10, Haemonetics(HAE) shares started trading at $85.04, with intraday highs of — and lows of —.

Trading volume for Haemonetics(HAE) stock has reached 0, versus its average volume of 924.82K.

Over the past 52 weeks, Haemonetics(HAE) stock has traded between a high of $88.59 and a low of $47.32.

HAE News

TipRanks 11h

Haemonetics Lifts Outlook on Broad-Based Earnings Strength

Haemonetics ((HAE)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock powerful investing tools with TipR...

Simply Wall St 24h

Is Haemonetics Undervalued As Q1 Earnings And Outlook Lift Optimism?

Advertisement Why Haemonetics Stock Is Back in Focus After Q1 Earnings Haemonetics (HAE) has attracted fresh attention after first quarter revenue of US$339.3...

Simply Wall St 2d

Haemonetics Stock Extends Run As Cash Flow Strength Meets Margin Pressure

Haemonetics stock came into this quarter on a tear, with shares up almost 60% over the past three months and another 3.3% added today. That kind of move sets a...

Analyst ratings

67%

of 12 ratings

Buy

66.7%

Hold

33.3%

Sell

More HAE News

TipRanks 3d

Haemonetics price target raised to $96 from $88 at Baird

Baird raised the firm’s price target on Haemonetics (HAE) to $96 from $88 and keeps an Outperform rating on the shares. The firm updated its model following big...

Nasdaq 3d

Haemonetics Corp Q1 Sales Increase

(RTTNews) - Haemonetics Corp (HAE) reported a profit for first quarter of $33.01 million The company's earnings came in at $33.01 million, or $0.72 per share....

TipRanks 7d

Haemonetics’ Vascade MVP system shows efficacy in electrophysiology study

Haemonetics (HAE) announced publication of a study providing new evidence supporting the safety and efficacy of Haemonetics’ Vascade MVP XL venous vascular clos...

People also own

Based on the portfolios of people who own HAE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.